Trial Profile
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas Undergoing Radiotherapy With or Without Standard Chemotherapy Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Armodafinil (Primary)
- Indications Fatigue
- Focus Therapeutic Use
- 30 May 2014 Results for 77 out of 80 patients presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 28 May 2014 New trial record